Skip to main content
. 2021 Jan 22;27:103–108. doi: 10.1016/j.ctro.2020.12.005

Table 2.

Doses measured with the in vivo dosimetry and calculated by the TPS Monaco on the chin on top and underneath the bolus for the 11 patients treated at the MRL. *Data of patient #9 were excluded because the measured value was more than 1.5 fold lower from the quartile Q(25)–Q(75) and median of the entire cohort (probably because film was not correctly placed). IQA = interquartile range.

Patient Dose measured on top of the bolus on chin (Gy) Dose measured underneath the bolus on chin (Gy) Dose calculated on top of the bolus on chin (Gy) Dose calculated underneath the bolus on chin (Gy) Absolute difference outside the bolus on chin (Gy) Absolute difference underneath the bolus on chin (Gy)
#1MRL 1.76 0.51 2.70 0.68 0.95 0.17
#2MRL 1.31 1.01 0.53 0.29 −0.78 −0.72
#3MRL 1.25 1.40 1.03 0.51 −0.22 −0.89
#4MRL 6.60 0.30 5.20 0.30 −1.40 0.00
#5MRL 1.20 0.86 2.31 1.25 1.11 0.40
#6MRL 2.43 0.00 4.46 0.54 2.03 0.54
#7MRL 3.15 0.11 4.73 0.52 1.58 0.42
#8MRL 1.38 0.81 2.94 0.83 1.56 0.02
#9MRL* 0.41 0.00 5.53 0.28 5.13 0.28
#10MRL 5.81 0.09 4.48 1.02 −1.33 0.93
#11MRL 2.06 0.72 2.70 0.36 0.65 −0.36
mean 2.69 0.56 3.11 0.63 0.42 0.07
Stand. Dev.* 1.95 0.39 1.29 0.25 1.08 0.45
Median* 1.91 0.62 2.82 0.53 0.80 0.10
IQA* 1.6 0.69 2.07 0.4 2.09 0.69